SOST and chronic kidney disease: Further, we analyzed Sclerostin levels according to CKD stages but did not find differences (CKD stage 2 = 24.9±11.4; CKD stage 3 = 28.8±10.2; CKD stage 4 = 25.7±9.3; p = .351).